scispace - formally typeset
M

Michela Biancolella

Researcher at University of Rome Tor Vergata

Publications -  43
Citations -  1281

Michela Biancolella is an academic researcher from University of Rome Tor Vergata. The author has contributed to research in topics: Gene & Medicine. The author has an hindex of 13, co-authored 37 publications receiving 896 citations. Previous affiliations of Michela Biancolella include University of Southern California.

Papers
More filters
Journal ArticleDOI

COVID-19 2022 update: transition of the pandemic to the endemic phase

TL;DR: In this paper , the authors reviewed the current state of research into the disease with focus on its history, human genetics and genomics and the transition from the pandemic to the endemic phase.
Journal ArticleDOI

Effects of dutasteride on the expression of genes related to androgen metabolism and related pathway in human prostate cancer cell lines

TL;DR: Investigating the cellular and molecular effects of dutasteride, a potent inhibitor of 5α-reductase type I and type II, in androgen-responsive (LNCaP) and androgens-unresponsive (DU145) human prostate cancer(PCa) cell lines shows that dutasterside reduces cell viability and cell proliferation in both cell lines tested.
Journal ArticleDOI

Valproic Acid Induces Neuroendocrine Differentiation and UGT2B7 Up-Regulation in Human Prostate Carcinoma Cell Line

TL;DR: It is observed that VPA promotes neuroendocrine-like differentiation associated with an increase in the expression of neuron-specific enolase, a decrease in prostate-specific antigen, and a down-regulation of androgen receptor protein, suggesting a modulation in the responsiveness to androgen therapy.
Journal ArticleDOI

COVID-19 2022 update: transition of the pandemic to the endemic phase

TL;DR: In this article , the authors reviewed the current state of research into the disease with focus on its history, human genetics and genomics and the transition from the pandemic to the endemic phase.
Journal ArticleDOI

COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy.

TL;DR: The authors in this article reviewed the current state at the milestone of 1 year into the pandemic, as declared by the WHO (World Health Organization), focusing first on two major topics: viral variants and the human genetic susceptibility to disease severity.